Literature DB >> 15310335

Estrogen-dependent induction of persistent vaginal candidosis in naïve mice.

M Hamad1, K H Abu-Elteen, M Ghaleb.   

Abstract

The capacity of estrogen to induce vaginal candidosis (VC) in the absence of previous or concurrent Candida albicans infections was examined. Adult female Balb/c mice were evaluated for vaginal C. albicans burden, C. albicans-specific delayed type hypersensitivity (DTH) responses and vaginal lymphocyte population kinetics at several time-points while receiving weekly injections of 0.5 mg estrogen. Estrogen treatment resulted in the appearance of significant levels of C. albicans vaginal colonization, which persisted for a period of 4 weeks. A marked suppression of DTH responses mounted against subsequent C. albicans challenge was observed. Absolute number of vaginal T lymphocytes gradually increased by several folds especially at weeks 5-6 following the start of estrogen treatment. These results clearly indicate that estrogen, independent of other predisposing factors, is capable of perturbing the commensal relationship between the host and the fungus, which results in the induction of persistent VC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15310335     DOI: 10.1111/j.1439-0507.2004.00994.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  9 in total

1.  Protocols for vaginal inoculation and sample collection in the experimental mouse model of Candida vaginitis.

Authors:  Junko Yano; Paul L Fidel
Journal:  J Vis Exp       Date:  2011-12-08       Impact factor: 1.355

2.  Patterns of Expression of Vaginal T-Cell Activation Markers during Estrogen-Maintained Vaginal Candidiasis.

Authors:  Ameera Al-Sadeq; Mawieh Hamad; Khaled Abu-Elteen
Journal:  Allergy Asthma Clin Immunol       Date:  2008-12-15       Impact factor: 3.406

3.  Exogenous Reproductive Hormones nor Candida albicans Colonization Alter the Near Neutral Mouse Vaginal pH.

Authors:  Jian Miao; Hubertine M E Willems; Brian M Peters
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

4.  Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis.

Authors:  Diego C Rossi; Julian E Muñoz; Danielle D Carvalho; Rodrigo Belmonte; Bluma Faintuch; Primavera Borelli; Antonio Miranda; Carlos P Taborda; Sirlei Daffre
Journal:  BMC Microbiol       Date:  2012-03-06       Impact factor: 3.605

5.  Estrogen treatment predisposes to severe and persistent vaginal candidiasis in diabetic mice.

Authors:  Mawieh Hamad
Journal:  J Diabetes Metab Disord       Date:  2014-01-08

6.  Feasibility of histological scoring and colony count for evaluating infective severity in mouse vaginal candidiasis.

Authors:  Jin-E Zhang; Dan Luo; Rong-Yi Chen; Yan-Ping Yang; Ying Zhou; Yi-Ming Fan
Journal:  Exp Anim       Date:  2013

Review 7.  Vulvovaginal Candidiasis: A Current Understanding and Burning Questions.

Authors:  Hubertine M E Willems; Salman S Ahmed; Junyan Liu; Zhenbo Xu; Brian M Peters
Journal:  J Fungi (Basel)       Date:  2020-02-25

Review 8.  Candida vaginitis: when opportunism knocks, the host responds.

Authors:  Brian M Peters; Junko Yano; Mairi C Noverr; Paul L Fidel
Journal:  PLoS Pathog       Date:  2014-04-03       Impact factor: 6.823

9.  Antifungal Activity of the Biphosphinic Cyclopalladate C7a against Candida albicans Yeast Forms In Vitro and In Vivo.

Authors:  Julian E Muñoz; Diego C P Rossi; Kelly Ishida; Cristina C Spadari; Marcia S C Melhem; Daniel M Garcia; Antonio C F Caires; Carlos P Taborda; Elaine G Rodrigues
Journal:  Front Microbiol       Date:  2017-05-03       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.